All News

    A Patient Guide to Understanding HER2-Positive Breast Cancer

    September 19th 2025, 4:00pm

    Article

    A guide for patients to understand HER2-positive breast cancer, treatment options by stage and how to talk with your oncologist.

    Vaccine Elicits Immune Responses in Pancreatic Cancer

    September 19th 2025, 3:00pm

    Article

    Among patients with pancreatic cancer, the vaccine ELI-002 7P elicited strong mKRAS-specific T cell responses in approximately 99% of patients.

    Accurate Kidney Cancer Diagnosis is Key to Effective Treatment

    September 19th 2025, 1:00pm

    Video

    Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox Chase Cancer Center.

    What Does Standing Up to Cancer Mean to You?

    September 18th 2025, 9:00pm

    Article

    A cancer survivor explains that we must all become involved in trying to bring back cancer research.

    From Patient to Author: Emphasizing Shared Decision Making in NSCLC

    September 18th 2025, 8:00pm

    Article

    Nancee Pronsati discusses a new patient-authored guide for managing ALK-directed treatment side effects in lung cancer and improving quality of life.

    Understanding Your Diagnosis: An Overview of Leukemia

    September 18th 2025, 7:00pm

    Article

    Leukemia is a blood cancer that disrupts normal cell production, leading to infection risk, anemia and bleeding, and requiring tailored treatments.

    Looking Back on the Shock of a Multiple Myeloma Diagnosis

    September 18th 2025, 5:00pm

    Article

    What is the first emotion that comes to mind about your cancer journey? For me, the strong emotion that I choose is shock!

    Beyond the Diagnosis: A Stage-by-Stage Guide to Multiple Myeloma Treatment

    September 18th 2025, 4:00pm

    Article

    Diagnosed with multiple myeloma? Our guide explains each stage and treatment, helping you engage confidently with your care team.

    FDA Approves Bosaya and Aukelso Biosimilars for Solid Tumor Care

    September 18th 2025, 3:00pm

    Article

    The FDA approved Bosaya and Aukelso, biosimilars of Prolia and Xgeva, respectively, for the treatment of solid tumors, like breast and prostate cancer.

    How to Access Support Resources for Rare Cancers

    September 18th 2025, 1:00pm

    Video

    Being diagnosed with a rare cancer like GIST can be overwhelming, highlighting the need for support networks, says Dr. Rosario Ligresti.